GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
103 hedge funds and large institutions have $259M invested in GenMark Diagnostics, Inc in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $59K
Holders
103
Holding in Top 10
–
Calls
–
Puts
$59K
Top Buyers
| 1 | +$5.72M | |
| 2 | +$3.39M | |
| 3 | +$3.21M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.15M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.09M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$3.1M | |
| 3 | -$2.86M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.49M |
| 5 |
Morgan Stanley
New York
|
-$2.39M |